Prion disease and anaesthesia;ANESTHESIE ET AGENTS TRANSMISSIBLES NON CONVENTIONNELS (OU MALADIES A PRIONS)

Annales Francaises d'Anesthesie et de Reanimation

Volumn 16, Issue 8, 1997, Pages 955-963

  Estebe J P ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Anesthesia; Prion; Prion disease

Indexed keywords

ANESTHESIA; BRAIN SPONGIOSIS; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DISEASE TRANSMISSION; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; KURU; NEUROPATHOLOGY; NONHUMAN; PRION DISEASE; REVIEW; SCRAPIE; ADULT; ANESTHESIOLOGY; ANIMAL; ANIMAL DISEASE; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; ECONOMICS; ENDOTRACHEAL INTUBATION; EQUIPMENT; INSTRUMENT STERILIZATION; INSTRUMENTATION; ISOLATION AND PURIFICATION; MOUSE; NEUROSURGERY; PATHOGENICITY; PHYSIOLOGY; PRION;

ADULT; ANESTHESIA; ANESTHESIOLOGY; ANIMAL DISEASES; ANIMALS; BLOOD TRANSFUSION; CATTLE; ENCEPHALOPATHY, BOVINE SPONGIFORM; EQUIPMENT CONTAMINATION; HUMANS; INTUBATION, INTRATRACHEAL; MICE; NEUROSURGICAL PROCEDURES; PRION DISEASES; PRIONS; STERILIZATION;

EID: 0031310731     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(97)82144-2     Document Type: Article

References (61)

1. Anderson RM, Donnelly CA, Ferguson NM, Woolhouse MEJ, Watt CJ, Udy HJ et al. Transmission dynamics and epidemiology of BSE in British cattle. Nature 1996;382:779-88
2. Pastoret PP, Hamers C, Brochier B. La transmissibilité interspé cifique des encéphalopathies spongiformes. Rev Med Liége 1996;51:705-13
3. Wisniewski HM, Sigurdarson S, Rubenstein R, Kascsak RJ, Carp RI. Mites as vectors for scrapie [letter]. Lancet 1996:347:1114
4. Diringer H. Proposed link between transmissible spongiform encephalopathies of man and animals. Lancet 1995;346:1208-10
5. Schreuder BEC, Van Keulen LJM, Vromans MEW, Langeveld JPM, Smits MA. Preclinical test for prion disease [letter]. Nature 1996;381:563
6. Dormont D. Les agents transmissibles non conventionnels ou prion. Press Med 1997;26:425-30
7. Delwaide PJ. La genèse de la notion de prion. Rev Med Liège 1996;51:695-713
8. Patterson WJ, Dealler SF. Bovine spongiform encephalopathy and possible risk to human health: food for thought. J Public Health Med 1995;17:261-8
9. Lasmézas CI, Deslys JP, Demaimay R, Adjou KT, Lamoury F, Dormont D et al. BSE transmission to macaques. Nature 1996:381:743-4
10. Ironside JW. Creutzfeldt-Jakob disease. Brain Pathol 1996:6:379-88
11. Gibbs CJ, Gajdusek DC, Asher DM, Alpers MP, Beck E, Daniel PM et al. Creutzfeldt-Jakob disease (subacute spongiform encephalopathy) transmission to the chimpanzee. Science 1968;161:388-9
12. Ghetti B, Dlouny SR, Giaccone G, Bugiani O, Frangione B, Farlow MR et al Gerstmann-Straüssler-Scheinker disease and the indiana kindred. Brain Pathol 1995:5:61-75
13. Fiorino AS. Sleep, genes and death: fatal familial insomnia. Brain Res Brain Res Rev 1996:22:258-64
14. Ghetti B, Piccardo P, Frangione B. Bugiani O, Giaccone G, Young K et al. Prion protein amyloidosis. Brain Pathol 1996:6:127-45
15. Palmer MS, Dryden AJ, Hughes JT, Collinge J. Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 1991:352:340-2
16. Billette de Villemeur T. Maladie de Creutzfeldt-Jakob : l'intrication du gène de la PrP, d'un agent non conventionnel et de l'hormone de croissance. Med Sci 1992:8:584-5
17. Brown P, Preece MA, Will RG. « Friendly fire » in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992;340:24-7
18. Delasnerie-Laupretre N. Alperovitch A. Epidemiology of Creutzfeldt-Jakob disease. Pathol Biol 1995:43:22-4
19. Schoene WC, Masters CL, Gibbs CJJr. Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease): atypical clinical and pathological findings. Arch Neural 1981;38:473-7
20. Weber T. Tumani H, Holdorff B, Collinge J, Palmer M, Kretzschmar HA et al. Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet 1993;341:123-4
21. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of « new variant » CJD. Nature 1996:383:685-90
22. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibiero K, Alperovitch A et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5
23. Chazot G, Broussolle E, Lapras CL, Blattler T, Aguzzi A. Kopp N. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996:347:1181
24. Deslys JP, Lasmézas CI, Streichenberger N, Hill A. Collinge J, Dormont D et al. New variant Creutzfeldt-Jakob disease in France [letter]. Lancet 1997:349:30-1
25. Kahn A, Bursaux E. Le lien entre encéphalopathie spongiforme bovine et le nouveau variant de la maladie de Creutzfeldt-Jakob. Med Sci 1997:13:62-5
26. Loftus B, Rogers M. Characterization of a prion protein (PrP) gene from rabbit a species with apparent resistance to infection by prion.Gene 1997:184:215-9
27. Budka H, Aguzzi A, Brown P, Brucher JM, Bugiani O, Gullotta F et al. Neurophatological diagnostic criteria for Creutzfeldt-Jakob disease (CDJ) and other human spongifotm encephalopathies (prion diseases). Brain Pathol 1995:5:459-66
28. Reznik M. Aspects neuropathologiques des maladies à prions. Rev Med Liège 1996:51:697-700
29. Lehman S. Le rôle de la protéine du prion dans les encéphalopathies spongiformes transmissibles humaines. Med Sci 1996:12:949-58
30. Prusiner SB, McKinley MP. Bowman KA. Bolton DC, Bendheim PE, Groth DF et al. Scrapie prions aggregate to form amyloid-like biréfringent rods. Cell 1983:35:349-58
31. Prusiner SB, McKinley MP, Groth DF, Bowman KA, Mock NI, Cochran SP et al. Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci États-Unis 1981:78:6675-9
32. Collinge J, Whittington MA. Sidle KCL, Smith CJ, Palmer MS, Clarke AR et al. Prion protein is necessary for normal synaptic function. Nature 1994:370:295-7
33. Estibeiro JP. Multiple roles for PrP in the prion diseases. Trends Neurosci 1996:19:257-8
34. Skegg DCG. Sacred cows, science and uncertainties. Nature 1996:382:755-6
35. Rentier B. Les prions : aspects moléculaires. Rev Med Liège 1996:51:700-5
36. Laurent M. Les maladies à prion : L'hypoth̀se de la « protéine seule » et ses conseéquences dynamiques. Med Sci 1996; 12:774-85
37. Dormont D, Bursaux E. Dernière heure : I'encéphalopathie spongiforme bovine : commentaires sur un cyclone. Med Sci 1996:12:673-5
38. Priola SA. Caughey B, Raymond GJ, Chesebro B. Prion protein and the scrapie agent : in vivo studies in infected neuroblastoma cells. Inf Agents Dis 1994:3:54-8
39. Weismann C. The prion's progress. Nature 1991:349:569-71
40. Weissman C. A « unified theory » of prion propagation. Nature 1991:352:579-83
41. Sailer A, Bueler H. Fischer M. Aguzzi A, Weissmann C. No propagation of prions in mice devoid of PrP. Cell 1994:77:967-8
42. Brandner S, Igenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y et al Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 1996;379:339-43
43. Blattler T, Brandner S, Raeber AJ, Klein MA, Volgtlander T, Weissmann C et al. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 1997:389:69-73
44. Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995:83:79-90
45. Lasmézas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM et al. Transmission of the BSE agent to mice in The absence of detectable abnormal prion protein. Science 1997:275:402-5
46. Zeidler M, Stewart GE, Barraclough CR, Bateman DE, Burn DJ et al. New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet 1997:350:903-7
47. Manuelidis L, Fritch W, Xi YG. Evolution of a strain of CJD that induces BSE-like plaques. Science 1997:277:94-8
48. Hill AF, Zeidler M, Ironside J, Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997:349:99-100
49. Hsich G, Kenney K, Gibbs CJJr, Lee KH, Harrington MG. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996:335:924-30
50. Zerr I. Bedemer M, Otto M, Poser S, Windl O, Kretzschmar HA et al. Diagnosis of Creutzfeldt-Jakob disease by two dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996:348:846-9
51. Brown P, Rohwer RG, Cajdusek DC. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue. J Infect Dis 1986;153:1145-8
52. Manuelidis EE, Kirn JH, Mericangas JR, Manuelidis L. Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet 1985;ii:896-7
53. Dealier S. A matter for debate: the risk of bovine spongiform encephalopathy to humans posed by blood transfusion in the UK. Transfus Med 1996:6:217-22
54. Flanagan P, Barbara JAJ. Prion disease and blood transfusion. Transfus Med 1996:6:213-5
55. Creange A, Gray F, Cesaro P, Degos JD. Pooled plasma derivatives and Creutzfeldt-Jakob disease [letter]. Lancet 1996:347:482
56. Manuelidis EE, Manuelidis L. A transmissible Creutzfeldt-Jakob disease-like agent is prevalent in the human population. Proc Natl Acad Sci États-Unis 1993:90:7724-8
57. Brown P. Can Creutzfeldt-Jakob disease be transmitted by transfusion. Curr Opin Haematol 1995:2:472-7
58. Heye N, Hensen S, Muller N. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1994:343:298-9
59. Esmonde TFG, Will RG, Slattery JM, Knight R, Harries-Jones R, De Silva R et al. Creutzfeldt-Jakob disease and blood transfusion. Lancet 1993:341:205-7
60. Goodbrand IA, Ironside JW, Nicolson D, Bell JE. Prion protein accumulation in the spinal cords of patients with sporadic and growth hormone associated Creutzfeldt-Jakob disease [letter]. Neuroscience 1995:183:127-30
61. Sleth JC, Knoen MF. Fabry J. Prions et anesthésie locorégionale. Réflexions à propos de la circulaire du 11 décembre 1995 [lettre]. Ann Fr Anesth Réanim 1997:16:203-4